ferric chloride has been researched along with Kidney Failure, Chronic in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiang, CK; Chien, CT; Hsu, SP; Yang, SY | 1 |
Chen, YC; Fang, JT; Hsu, PY; Huang, JY; Jenq, CC; Tian, YC; Wu, HH; Yang, CW | 1 |
Hricik, DE; Hussain, R | 1 |
Era, S; Kaneda, F; Kouji, H; Manno, S; Matsuzawa, N; Nagasawa, T; Soejima, A; Takakuwa, Y | 1 |
Hanson, SY; Johnson, AC; Wasse, H; Zager, RA | 1 |
1 trial(s) available for ferric chloride and Kidney Failure, Chronic
Article | Year |
---|---|
N-acetylcysteine for the management of anemia and oxidative stress in hemodialysis patients.
Topics: Acetylcysteine; Administration, Oral; Adult; Aged; Aged, 80 and over; Anemia; Antioxidants; Case-Control Studies; Chlorides; Dinoprost; Erythropoietin; Female; Ferric Compounds; Hematocrit; Humans; Kidney Failure, Chronic; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress; Recombinant Proteins; Renal Dialysis | 2010 |
4 other study(ies) available for ferric chloride and Kidney Failure, Chronic
Article | Year |
---|---|
Effectiveness of oral and intravenous iron therapy in haemodialysis patients.
Topics: Administration, Oral; Anemia, Iron-Deficiency; C-Reactive Protein; Chlorides; Erythropoietin; Female; Ferric Compounds; Ferritins; Ferrous Compounds; Hematinics; Hematocrit; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Treatment Outcome | 2008 |
Pancytopenia and hepatosplenomegaly in oxalosis.
Topics: Adult; Bone Marrow; Calcium Oxalate; Chlorides; Female; Ferric Compounds; Hepatomegaly; Humans; Kidney Failure, Chronic; Pancytopenia; Splenomegaly | 1984 |
Useful markers for detecting decreased serum antioxidant activity in hemodialysis patients.
Topics: Adenosine Monophosphate; Albumins; Antioxidants; Biomarkers; Chlorides; Chromatography, High Pressure Liquid; Erythrocyte Membrane; Female; Ferric Compounds; Humans; Kidney Failure, Chronic; Lipid Peroxidation; Male; Membrane Lipids; Middle Aged; Oxidation-Reduction; Oxidative Stress; Renal Dialysis; Thiobarbituric Acid Reactive Substances; Thionucleotides; Uremia | 2002 |
Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury.
Topics: Animals; Aorta; Cell Division; Cell Line; Cell Line, Transformed; Cell Survival; Chlorides; Endothelium, Vascular; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Iron-Dextran Complex; Kidney Failure, Chronic; Kidney Tubules, Proximal; Lipid Peroxidation; Male; Malondialdehyde; Mice; Oligosaccharides; Oxidants; Parenteral Nutrition | 2002 |